Our Current Project
P2i Baby – Safe Pregnancy & Healthy Children
The Forum Institute (501(c)(3) nonprofit organization) is widely recognized by academic institutions and the government as the largest and most successful think tank in the United States focusing on Special Needs Children. In 2014, The FORUM began a very ambitious public health initiative called P2i (Preconception to Infancy) in order to build scientific consensus around an evidence- based protocol to significantly increase the rate of safe pregnancies and healthy children.
P2i Baby™ Virtual Campus
What is P2i?
P2i stands for Preconception to Infancy.
A revolutionary approach to the practice of medicine that reduces miscarriages and helps ensure infants a healthy start in life.
Step-by-step guidance, based on hard science, that can dramatically increase a woman’s odds of delivering a full-term baby who will not suffer from chronic disorders like ADHD, cancer, serious allergies and autism. The goal of the P2i initiative is to positively affect one million babies’ lives in five years. The Forum™ and P2i® are trademarks of The Forum.
The Forum’s P2i Faculty
The Forum Board – Executive Committee
The Forum Board
Accomplishments – National award major publications
THE 2015 IACC SUMMARY OF ADVANCES IN AUTISM SPECTRUM DISORDER RESEARCH
Each year, the IACC releases its annual list of scientific advances that represent significant progress in the field. The 20 studies selected have given new insight into the underlying biology of autism spectrum disorder (ASD) and potential risk factors, examined the state of the science in early screening and diagnosis, and evaluated promising early intervention strategies. The advances also address health outcomes for children and adults with autism, and issues related to education, transition to adulthood, and employment.
PEDIATRICS – Early Identification and Interventions for Autism Spectrum Disorder: Executive Summary, 2015
Autism spectrum disorders (ASDs) are neurodevelopmental disorders characterized by impaired social communication skills and isolated areas of interest. The current prevalence of these disorders is estimated to be 1 in 68, and recent estimates of the risk of recurrence in families with at least 1 child diagnosed with ASD are 10% to 19%. Advances have been made in identifying genetic variants that can account for biological vulnerability to ASD, although recent studies examining patterns of heredity implicate environmental factors and potential gene-by-environment interactions.
PEDIATRICS – Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders – 2010
Autism spectrum disorders (ASDs) are common and clinically heterogeneous neurodevelopmental disorders. Gastrointestinal disorders and associated symptoms are commonly reported in individuals with ASDs, but key issues such as the prevalence and best treatment of these conditions are incompletely understood. A central difficulty in recognizing and characterizing gastrointestinal dysfunction with ASDs is the communication difficulties experienced by many affected individuals.
NIEHS/EPA Children’s Environmental Health and Disease Prevention Research Center
Environmental exposures in the earliest stages of human development—including before birth—influence the occurrence of disease later in life. Since 1997, the U.S. Environmental Protection Agency (EPA) and the National Institute of Environmental Health Sciences (NIEHS) have partnered to investigate new frontiers in the field of children’s environmental health research by supporting research devoted to children’s environmental health and disease prevention.
Project TENDR: Targeting Environmental Neuro-Development Risks
Children in America today are at an unacceptably high risk of developing neurodevelopmental disorders that affect the brain and nervous system including autism, attention deficit hyperactivity disorder, intellectual disabilities, and other learning and behavioral disabilities. These are complex disorders with multiple causes—genetic, social, and environmental. The contribution of toxic chemicals to these disorders can be prevented. Approach: Leading scientific and medical experts, along with children’s health advocates, came together in 2015 under the auspices of Project TENDR: Targeting Environmental Neuro-Developmental Risks to issue a call to action to reduce widespread exposures to chemicals that interfere with fetal and children’s brain development.
OBGYN: Committee Opinion
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women and the American Society for Reproductive Medicine Practice Committee with the assistance of the University of California, San Francisco (UCSF) Program on Reproductive Health and the Environment. The Program on Reproductive Health and the Environment endorses this document. This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. This information should not be construed as dictating an exclusive course of treatment or procedure to be followed.
Heavy Metal Contamination of Prenatal Vitamins
Prenatal vitamins are often consumed daily during gestation and postnatally for up to 18-24 months with belief that supplementation achieves better outcomes. Detrimental effects of gestational exposure to adverse chemical agents are gathering increasing attention. This study was designed to asses toxic element contamination in prenatal supplements.
JAMA: Call to Action on Neurotoxin Exposure in Pregnant Woman and Children
Citing an alarming increase in childhood neurodevelopmental disorders such as autism and attention-deficit/hyperactivity disorder (ADHD), a group of scientists, health professionals, and children’s health advocates is calling for increased monitoring, assessment, and reduction of neurotoxic chemicals.